Jumpcan Pharmaceutical is a national high-tech enterprise group, the National Torch Program pharmaceutical industry backbone enterprise, one of top 100 of national pharmaceutical industry, and the Shanghai Stock Exchange A-share listed company (stock code: 600566), and focusing on the R & D, manufacturing and trading of Chinese traditional medicine, Western medicine, daily use chemical based on Chinese traditional medicine, and Chinese medicine health products. The company has two subsidiaries, Jumpcan Pharmaceutical Group Co., Ltd. and Shanghai Jijia Investment Co., Ltd. Jumpcan Pharmaceutical Group Co., Ltd. has several subsidiaries including Tianji Pharmaceutical, Jiyuan Medicine, Jiren Medicinal Slices, Pudilan Daily Use Chemicals, Kangxuyuan Health Products, Ginkgo Industry Research Institute, Oral Health Research Institute and Haiyuan Property; Shanghai Jijia Investment Co., Ltd. has few subsidiaries including Ningbo Jijia Investment and Dongke Pharmacy.
Jumpcan Pharmaceutical promotes the entrepreneurial spirit of "helping each other in the same boat and being tolerant to diversity" and the core values of "innovation, hard work and win-win", performs the talent concept of "talent-oriented, talent-based, retaining talents by undertaking, remuneration and affection”, implements the team management culture of "advocating hard work, discipline and rules", and proposes the moral character of "two-capability and two-sincerity, two-have and two-observe", constantly creating "five senses" and enhancing "three forces", organizing harmonious cultural activities for Jumpcan staff, building "nine-one" cultural platform, and leading the business development by characteristic corporate culture.
Jumpcan Pharmaceutical adheres to the enterprise mission of "using technology to defend the health", advocates the R & D concept of "leading the forefront, creating competitive products", focusing on R & D, production and sales of drugs in preponderant fields including "pediatrics, gynecology, pneumology, gastroenterology and geriatrics", and expanding daily use chemical based on Chinese traditional medicine, and Chinese medicine health products. The company has more than 10 formulations, over 210 strengths and specifications of No. National Drug of Character Zhun, where more than 110 strengths and specifications are included in the National Directory of Insured Drugs, 68 strengths and specifications are included in the National Directory of Basic Drugs. The company obtained 38 national invention patents, with more than 10 varieties listed as the Exclusive Domestic Varieties, Exclusive Formulations, High-tech Products in Jiangsu Province and Famous Brand of Jiangsu Province, including Pudilan, Methylene Blue and Chuanxiong, "Shoupai" and "Tongxiao" trademarks are famous in Jiangsu Province, and "Shoupai" trademark is also "Famous Chinese Trademark"; Pudilan Anti-inflammatory Oral Liquid obtained “The Fourteenth Excellent National Patent Award" and "Excellent Quality Award"; the new generation of proton pump inhibitor Rabeprazole Sodium Enteric Capsules (Jinuo) won the title of "2015 Excellent Brand of Digestive System in Chinese Chemical Pharmaceutical Industry"; and one pharmaceutical composition for curing exogenous fever and its preparation method (Tongbei) won the 17th Excellent Chinese Patent Award. The daily use chemical based on Chinese traditional medicine led by "PudilanKeyanning Toothpaste" and Chinese medicine health products led by "Wuxiancao" will keep enhancing the company’s core market competitiveness and promoting the rapid development of big health undertaking.
Jumpcan Pharmaceutical is about to "building ten billion scale, cultivating top-100 enterprise, creating century brand", has developed the strategic development plan of "expanding the industrial chain, extending product groups, and developing big health undertaking", full implementing the overall strategic layout of combining "three businesses" - Chinese traditional and western medicine, daily use chemical based on Chinese traditional medicine, and Chinese medicine health products - and “two wings” - capital operation and public service, and striding forward to a strategic goal of large-scale, capital operational and international development. A high quality, modern, garden-style large pharmaceutical group will be erected in the Yangtze River and stand proudly in the forest of the world's pharmaceutical companies.